ICD-10 Code B37.1 | Pulmonary candidiasis Symptoms, Diagnosis, Billing

Pulmonary candidiasis is a fungal infection of the lungs caused by Candida species, primarily affecting immunocompromised individuals. It is clinically significant due to its potential to cause severe respiratory distress and complications. The ICD-10 Code B37.1 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring proper management and treatment of affected patients.

What is ICD-10 Code B37.1 for Pulmonary candidiasis?

ICD-10 Code B37.1 represents Pulmonary candidiasis, a condition characterized by the presence of Candida fungi in the pulmonary system. This code is used when documenting cases of pulmonary infection due to Candida, particularly in patients with underlying immunosuppression or other risk factors. It is essential for accurate clinical documentation and billing, ensuring appropriate treatment and resource allocation.

ICD-10 Code B37.1 – Clinical Definition and Explanation of Pulmonary candidiasis

Pulmonary candidiasis is primarily caused by the overgrowth of Candida species in the lungs, often occurring in immunocompromised patients, such as those with HIV/AIDS, cancer, or those undergoing immunosuppressive therapy. The condition can progress rapidly, leading to significant respiratory complications, necessitating prompt medical intervention.

Key Clinical Features:

• Cough, often productive with sputum
• Fever and chills, indicating systemic infection
• Dyspnea or difficulty breathing
• Chest pain or discomfort
• Wheezing or abnormal lung sounds on auscultation

ICD-10 Code B37.1 for Pulmonary candidiasis – SOAP Notes & Clinical Use

ICD-10 Code B37.1 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment of patients with pulmonary candidiasis. It plays a crucial role in both acute and chronic care settings, ensuring comprehensive documentation of symptoms and treatment plans.

What Does ICD-10 Code B37.1 for Pulmonary candidiasis Mean in SOAP Notes?

In SOAP notes, ICD-10 Code B37.1 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of pulmonary candidiasis. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code B37.1 – Pulmonary candidiasis

Pulmonary candidiasis requires prompt medical attention, often necessitating hospitalization for severe cases. Treatment typically involves antifungal therapy and supportive care.

Antibiotic Therapy:

• First-line: Fluconazole (400-800 mg IV/PO daily for 14-21 days)
• Alternative: Amphotericin B (0.5-1 mg/kg IV daily for 1-2 weeks)
• Alternative: Voriconazole (6 mg/kg IV every 12 hours for 2 doses, then 4 mg/kg IV every 12 hours)

Supportive Care:

• Oxygen therapy to manage hypoxemia
• Fluid management to prevent dehydration
• Monitoring for respiratory distress and complications

Infection Control:

• Implement standard precautions to prevent spread
• Isolate patients with severe immunosuppression during outbreaks
• Educate healthcare staff on infection control measures

How to Document Symptoms of Pulmonary candidiasis (ICD-10 B37.1) in SOAP Notes

Subjective:

• Patient reports persistent cough with yellow-green sputum
• History of fever and chills over the past week
• Complaints of shortness of breath, especially during exertion
• Recent hospitalization for chemotherapy treatment

Objective:

• Vital signs: Temperature 101°F, Respiratory rate 24 breaths/min
• Oxygen saturation: 88% on room air
• Auscultation reveals bilateral wheezing and crackles
• Chest X-ray shows infiltrates consistent with fungal infection

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Pulmonary candidiasis (ICD-10 Code B37.1)

Assessment:

• Diagnosis: Pulmonary candidiasis, moderate severity
• ICD-10 Code: B37.1
• Contributing factors: Recent chemotherapy and immunosuppression
• Consider differential diagnoses such as bacterial pneumonia

Plan:

• Initiate antifungal therapy with fluconazole
• Provide supplemental oxygen as needed
• Educate patient on recognizing worsening symptoms
• Schedule follow-up in one week to reassess respiratory status

Treatment & Plan Section for ICD-10 Code B37.1 – Pulmonary candidiasis

• First-line antifungal treatment with fluconazole or amphotericin B
• Supportive care including oxygen therapy and hydration
• Patient education on symptom monitoring and adherence to treatment
• Regular follow-up appointments to monitor treatment response

Using ICD-10 Code B37.1 for Pulmonary candidiasis in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings in SOAP notes
• Use B37.1 for billing in cases of confirmed pulmonary candidiasis
• Align treatment plans with clinical guidelines to support billing justification
• Document any comorbidities or complications that may affect treatment

Related ICD-10 Codes Often Used with Pulmonary candidiasis

• B37.0 – Candidiasis of skin and mucous membranes
• B37.9 – Candidiasis, unspecified
• B20 – HIV disease

ICD-10 Code B37.1 in Medical Billing and Insurance for Pulmonary candidiasis

ICD-10 Code B37.1 is crucial for billing in hospital, ER, or infectious disease care settings, ensuring accurate reimbursement for services rendered.

Billing Notes:

• Document all relevant clinical findings and treatment plans to support the claim
• Use B37.1 in conjunction with other codes for comorbidities as needed
• Ensure that the diagnosis is clearly linked to the services provided in the medical record

Common CPT Pairings: